Objective: In the present study, the utilization of a novel biocompatible and biodegradable Methotrexate controlled release injectable formulation is established. The drug delivery vehicle used is an autogelling pH sensitive formulation, which is based on the natural biopolymer chitosan.
INTRODUCTION
Anticancer agents are usually used at their maximum tolerated dose in order to achieve the highest possible effect on quickly dividing malignant cells. However, at these dose levels, the enclosure of treatment-free periods is vital to permit the recovery of normal cells in the body. Furthermore, it is seen that during these rest periods, there is regrowth of the vascular endothelial cells which supports the tumor mass, resulting in more progression of the more aggressive cancers generating higher resistant to the cytotoxic drugs. Moreover, the continuous drug infusions have confirmed that constantly low blood levels of these anticancer agents can be more effective in comparison to the intense high doses at short intervals. Also, the continuous infusions for longer duration like weeks or months may not be feasible due to cost and patient compliance issues. The hydrogels are three-dimensional, cross-linked networks of water-soluble polymers generally offering variable physical properties. Then, hydrogels can be formulated in an array of physical *Address correspondence to this author at the Pranveer Singh Institute of Technology, Kanpur, 209305-India; Tel: +91, 9450560321; E-mail: swatantrakushwaha15@gmail.com forms, including slabs, microparticles, nanoparticles, coatings as well as films. On the basis of the above study the, hydrogels have proved their use in clinical practice and experimental medicine for a variety of applications like tissue engineering and regenerative medicine [1] , diagnostics, cellular immobilization, as well as in the separation of biomolecules or cells [2] .
Hydrogels show limited tendency to adsorb proteins from body fluids due to their low interfacial tension. Further, the capability of molecules of different sizes to diffuse into (drug loading) and out of drug release allows the possible use of dry or swollen polymeric networks as drug delivery systems for a variety of usage like oral, nasal, buccal, rectal, vaginal, ocular and parenteral routes of administration. Several terms have been coined for hydrogels, such as 'intelligent gels' or 'smart hydrogels [3] . Moreover, the smartness of any material is majorly based on its ability to receive, transmit or process a stimulus, and then respond by producing the desired effect. Action on these stimuli results in changes in various involved phases, shapes, optics, mechanics, electric fields, surface energies, reaction rates, and permeation rates [4, 5] . Hydrogels are 'smart' or 'intelligent' in the sense through which they can perceive the existing stim-uli and accordingly respond by exhibiting changes in their physical or chemical nature, resulting in the release of entrapped drug in a controlled way [6] [7] [8] [9] .
Chitosan [10] [11] [12] is soluble, mucoadhesive and highly active as an absorption enhancer in its protonated form as the pKa of the amine groups of chitosan is 6.2. The chitosan at neutral pH hardly carries a charge possessing low solubility and hence is readily inactive. Because of the presence of functional groups like amine and hydroxyl, various chemical chitosan derivatives have been synthesized and studied for different applications. Moreover, chitosan has shown in situ gelling properties due to the development of the inter and intramolecular disulfide bonds at the physiological pH [13] .
MATERIALS
Methotrexate was obtained from the East and West Pharma Pvt. Ltd. Roorkee. Chitosan (Deacetylation degree DDA = 80%), and β-Glycerol phosphate were obtained from HiMedia Laboratories Pvt. Ltd., Mumbai, India and the Glyceryl monooleate (GMO) was obtained from Estelle Chemicals Pvt. Ltd., Ahmednagar, India. Demineralized and double distilled water was used. All chemicals, as well as the reagents used in this study, were of analytical grade.
METHODS

Preparation of In-situ forming pH Sensitive Hydrogels
Chitosan/glyceryl monooleate (C/GMO) solutions were prepared in 0.33 M citric acid [14] . The specified weighed quantity of Drug and Chitosan was stirred with an appropriate quantity of 0.33 M Citric acid for 3 hours in desired concentration according to ( Table 1) . The solution was further cooled up to 4 0 C and the desired amount of Glycerol Monooleate was added dropwise with constant stirring to get 10 ml homogenous clear liquid as final volume. These final solutions were filtered by cellulose membrane and finally developed pH sensitive formulations were sterilized by moist heat sterilization technique by autoclaving at 121 0 C for about 20 minutes.
Chitosan/GMO/Drug formulations were developed at room temperature by dispersing the powdered Methotrexate in chitosan solutions consistently under the aseptic conditions. Then in-situ hydrogels were prepared with Methotrexate. The chitosan was used as the delivery vehicle having the pH-sensitive properties. Chitosan solution formulated at physiological pH remained liquid. At acidic solutions of chitosan, when exposed to alkaline pH or body biological pH, it loses this charge and forms viscous gels. Hence, this can be a better carrier for the development of the pH-sensitive hydrogels.
Physicochemical Characterization
X-ray Diffractometry
The solid structure of the Drug was determined by the crystal X-ray scattering measurements. The XRD patterns were obtained with a Seifert Germany ISO debyeflex 2002 apparatus (Japan) using Cu-K α radiation (λ = 1.541 nm), a voltage of 40 kV and a 100 mA current. Also, the samples were scanned from 0-60° 2θ for qualitative assessment at a scanning rate of 4°/ min.
FTIR Spectroscopy
The FT-IR spectrum of the obtained sample of the drug was compared with the standard FT-IR spectra of the pure drug candidate.
Determination of λmax
The λmax of the given drug sample was determined by using UV-Vis spectrophotometer (UV-1700 Pharma Spec).
Standard Calibration Curve of Methotrexate
Accurately weighed 20 mg of crude Methotrexate Hydrochloride was dissolved in 100 ml of Phosphate buffer with a pH 7.4 to get the strength of 200µg/ml which was further diluted with buffer to obtain the final stock solution of 20µg/ml. From the stock solution, aliquots of 1, 2, 3, 4, 5, 6 & 7 ml were withdrawn and further diluted up to 10 ml with buffer to achieve the concentrations range of 2 to 14µg/ml. Moreover, the absorbance of the solutions was measured at 258 nm by using UV-Vis spectrophotometer (UV-1700 Pharma Spec). Finally, the calibration curve was plotted between the concentration vs. absorbance.
pH
The pH of in-situ forming Hydrogel formulation should be such that the developed formulation will be stable at that pH along with no sign of irritation to the patient during administration of the formulation. It is recommended that the formulations should have a pH range of 5.5 to 7.4. All the pH-sensitive Hydrogel formulations were evaluated for the desired pH by using Elico India Systronics digital pH meter.
In vitro Gelation Studies
All the pH-sensitive formulations were evaluated for gelling capacity [15] . The gelling capacity was determined by placing a drop of the developed system in a clean vial already containing 2 ml of pH 7.4 Phosphate buffer freshly prepared and equilibrated at 37° C and the visual assessment of the gel formation was carried out by noting the time for gelation as well as the time taken for the formed gel to dissolve. Further, lowest scores (+) were assigned to those products which have the phase transition only after 60-90 sec. and the formed gels collapsed within 1-2 hrs. The highest scores (+++) were assigned to those products which commenced phase transition within 60-90 sec. and the gels thus formed were stable for about 7-8 hrs. The moderate scores (++) were assigned to those products, which could form the gel in 60-90 sec. but failed to uphold the vital gel structure for more than 3 hrs.
In vitro Viscosity Studies
Viscosity is the main requirement of an in situ gelling structure. Viscosities of liquid formulations and gel formulations are important in the determination of the efficacy of insitu forming Hydrogels. Furthermore, an in-situ gelling formulation should attain an optimum viscosity to allow easy injection into the body with minimum pain, with a rapid solto-gel transition. Viscosity also affects the residence time of drug in the body. Hence, all the pH-sensitive formulations were evaluated for the viscosity of liquid formulations and viscosity of gelled formulations using the Brookfield viscometer (DV-II + Pro) in the small volume adapter. The viscosity of prepared pH-sensitive hydrogel formulations measured at 10 rpm was utilized for comparative evaluation.
In vitro Release Studies
The in vitro release of pH-sensitive Methotrexate formulations was carried out through cellophane membrane using a Type-I USP dissolution apparatus. For the study, the used dissolution media of Phosphate buffer pH 7.4 was freshly prepared. A 2-ml volume of the gelled formulation was accurately kept in Cellophane membrane, formerly soaked overnight in the dissolution medium to form a cellophane pouch. Then, this Cellophane membrane pouch containing the drug was kept in the cylindrical basket which was attached to the metallic driveshaft and suspended in 900 ml of dissolution medium maintained at 37± 1° C. The dissolution medium was stirred at 50 rpm and the aliquots, each of 5-ml volume, were withdrawn at the standard intervals and replaced by the equal volume of fresh dissolution medium to maintain the sink conditions. The aliquots were further analyzed by UVVis spectrophotometer (UV-1700 Pharma Spec) at 258 nm.
Drug Release Kinetics Studies
The Drug release data obtained from all formulations were subjected to be fitted into various mathematical models as given below in order to determine the Drug release kinetics of prepared formulations:
Cumulative percent drug released Vs. Time (Zero order rate kinetics).
Log Cumulative percent drug retained Vs. Time (First-order rate kinetics).
Cumulative percent released Vs. Root T [Higuchi's classical diffusion equation (Higuchi matrix)].
The 60 % drug release data was first fitted in the Korsmeyer-Peppas model to find out the mechanism of the drug release, where Log of cumulative percent drug released was plotted against Log Time. The present model was utilized to study drug release machinery by analyzing 'n' as the diffusion exponent significantly. It was found out that this model represented 'n' b/w 0.45 to 0.5 as the Fickian mechanism, 0.5 to 0.8 as the Non-Fickian and 0.8 to 1.0 the Case-II transport i.e. a zero-order mechanism prevails the drug release mechanism of the developed gel formulations.
RESULTS AND DISCUSSION
Powder X-Ray Diffractometry
In the X-ray di raction spectrum, Methotrexate exhibited various fine characteristic crystalline peaks b/w 2θ =7 0 to 27 0 confirming the highly crystalline nature of the drug.
PXRD Pattern for the Methotrexate is shown in Fig. (1) .
IR Spectroscopy
The IR spectrum of the pure Methotrexate sample was recorded by FTIR spectrometer is shown in Fig. (2) , which was further compared with standard IR spectra of Methotrexate.
Preformulation studies were conducted to assess the compatibility of pure drug Methotrexate with the set of polymers Chitosan and Glycerol monooleate prior to the preparation of hydrogels. The individual IR spectra of the pure drug as well as physical mixtures of Methotrexate with polymers are shown in Figs. (2 and 3) , indicating no interaction between Methotrexate and polymers when compared with the spectra of the pure drug with respect to the functional group present.
Appearance
Clarity of all the formulations was found to be satisfactory to the significant levels which are clearly justified in Table 2 showing the appearance and clarity for pH-induced gelling formulations.
pH
The pH of the formulations was found to be satisfactory and in the range of 6-7.4. It was observed that the formulations remained liquid at room temperature as well as at the pH at which they were formulated. It was shown that the terminal sterilization by autoclaving had imparted no remarkable effect on the pH. Table 2 shows the pH for pHinduced gelling formulations.
In-vitro Gelation Studies
The key requirement of an in situ gelling systems is gelling capacity (speed as well as the extent of gelation). It is essential that the formulation should have an optimum gelling capacity so that after injection, it would undergo a rapid sol-to-gel transition at the site of action, and would preserve its integrity without dissolving or eroding for an extended period of time. Table 2 shows the gelling capacity of all pH-induced gelling formulations. All the formulations showed instantaneous gelation when contacted with the Phosphate Buffer pH 7.4. The formulation F0 is the blank formulation which shows slow gelation. Formulations F1and F2 showed immediate gelation and maintained its integrity for few hours, while formulations F3, F4, and F5 showed immediate gelation for the prolonged period.
Viscosity Studies of Liquid Formulations and Gelled Formulations
An injectable formulation should have optimum viscosity, offering easy injection into the body as a liquid, facilitating the rapid sol-to-gel transition. The viscosity of the gelled formulation is also a key factor for determination of residence time of drug in the body. Table 3 shows the viscosity and gelled form of all pH-induced gelling formulations in liquid form and in gelled form at 10 rpm.
The pH-induced gelling formulations had increased the viscosity in proportional concentration as both chitosan and GMO had contributed as the viscosity enhancer. All pHinduced gelling formulations showed optimum viscosity in liquid form and gelled form except for formulation F5 which showed high viscosity in liquid and gelled form due to highest concentrations of chitosan and GMO.
Stability Studies
The formulations were selected for considering the stability studies. These formulations were tested in different temperature and humidity variation as per ICH guidelines to obtain the best suitable atmosphere for the storage condition of formulation and course of its time period till drug strength decreases due to its storage conditions. The formulations were subjected to stability testing at: Long-term (25˚C ± 2˚C/ 60% RH ± 5% RH), Intermediate (30˚C ± 2˚C / 65% RH ± 5% RH), Accelerated 40˚C ± 2˚C/ 75% RH ± 5% RH) and Storage in a refrigerator: Long-term (5˚C ± 3˚C) for a period of three month. The observations are shown in Table 4 . The formulations kept at 5˚C ± 3˚C did not show any significant decrease in the drug content, followed by the formulations kept at 25˚C ± 2˚C and at 30˚C ± 2˚C whereas the formulations kept at 40˚C ± 2˚C showed significant loss in the drug content. So, from the stability study data, it can be concluded that the formulations are most stable when stored at lower temperature or in refrigerator i.e. 5˚C ± 3˚C. The formulations F2 and F4 showed maximum stability than the other formulation.
In Vitro Release Studies
Increasing efforts have been made to exploit physiological signals such as pH for sustained drug delivery applications. Of the stimuli, pH has been widely investigated for the treatment of solid tumors. Numerous reports have demonstrated that inflamed or neoplastic tissues could exhibit a lower pH value (acidosis) than healthy tissue. Therefore, drug release to solid tumors can be achieved by designing pH-sensitive drug formulation, which disintegrates and releases the entrapped drugs in response to a lower pH specifically at the tumor site.
All the pH-sensitive in situ gelling formulations of Methotrexate were subjected to in vitro release studies. These in vitro release studies were conducted with the Phosphate buffer of pH 7.4. The results clearly showed that the gel formulations have the ability to retain the drug for a prolonged period of time (8 hours) and assured that the premature drug release will not occur.
Drug Release Kinetics Studies
The plots of zero order, first order, Higuchi matrix and Peppas for all pH-sensitive hydrogels are shown in Table 4 . The regression coefficient (r) and 'n' values of zero order, first order, Higuchi matrix and Peppas have been arranged in Table 5 for pH-induced gelling formulations respectively.
On the observation basis, it was found out that in the case of pH-induced gelling formulations, the best fit model was Zero order, signifying swelling-controlled diffusion. Whereas 'n' exponent value was between 0.5 to 0.89 representing that the formulation is released by Non-fickian diffusion mechanism. Fig. (4) . In-Vitro Drug Release Profile of Methotrexate from pH-induced gelling formulations (n=3). 
